News
NEW YORK, NY / ACCESS Newswire / April 14, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and ...
Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results